Controlled study to investigate management methods of gout attack for gout patients with uric-acid lowering therapy - FORTUNE-1

Clinical research consortium on uric acid0 个研究点目标入组 250 人开始时间: 2012年7月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients who meet any of the sixteen criteria below are ineligible for the study: 1) Patients who have previous history of hypersensitivity to febuxostat; 2) Patients who have previous history of hypersensitivity to colchicine; 3) Patients who have previous history of hypersensitivity to NSAIDs or patients who have not been affected by NSAIDs; 4) Patients who had gout attack in the last two weeks; 5) Patients who have used any uric-acid lowering drugs in the last four weeks; 6) Patients with secondary hyperuricemia; 7) Patients who have twice as high AST or ALT as the hospital's reference value; 8) Patients with serum creatinine level of 2.0 mg/dL or higher; 9) Patients who have or have had past history of malignant tumor as a complication requiring treatment; 10) Patients who are being treated with either mercaptopurine hydrate or azathioprine; 11) Patients with peptic ulcer; 12) Patients with serious hematological disorder; 13) Patients with serious cardiac disorder; 14) Patients with aspirin-induced asthma or its previous history; 15) Patients who participated in another clinical study or clinical trial in the six months prior to the confirmation of eligibility; 16) Patients who the doctor in charge judges are ineligible for the study.

发起方

Clinical research consortium on uric acid